
Sign up to save your podcasts
Or


Dr Bill Nelson and Dr Michael Pishvaian discuss the targeting of KRAS mutations in pancreatic cancer to develop new treatment options for a disease that has been historically difficult to care for.
By Johns Hopkins Kimmel Cancer Center4.6
99 ratings
Dr Bill Nelson and Dr Michael Pishvaian discuss the targeting of KRAS mutations in pancreatic cancer to develop new treatment options for a disease that has been historically difficult to care for.

32,067 Listeners

40 Listeners

5 Listeners

26 Listeners

823 Listeners

5 Listeners

302 Listeners

112,105 Listeners

56,649 Listeners

321 Listeners

45 Listeners

16 Listeners

2 Listeners

25 Listeners

8,189 Listeners

623 Listeners

58,190 Listeners

155 Listeners

833 Listeners